Generation Bio

Generation Bio Revenue

Delisted

The The revenue of Generation Bio (GBIO) as of Nov 10, 2026 is 19.89 M USD. In the previous year, The revenue was 5.90 M USD — a change of 236.92% (higher).

Revenue

19.89 MUSD

YoY

236.92%

Last updated:

In 2024, Generation Bio's sales reached 19.89 M USD, a 236.92% difference from the 5.90 M USD sales recorded in the previous year.

Over the last 6 years Generation Bio grew revenue by 186.5% annually, reaching 19.89 M USD.

The Generation Bio Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
Date
Revenue
Jan 1, 2022
880,000.00 USD
Jan 1, 2023
5.90 M USD
Jan 1, 2024
19.89 M USD
Jan 1, 2025 (e)
11.49 M USD
Jan 1, 2026 (e)
3.83 M USD
Jan 1, 2027 (e)
11.49 M USD
Jan 1, 2028 (e)
5.75 M USD
Jan 1, 2029 (e)
5.75 M USD
The Generation Bio Revenue history
YEARRevenueYoY
est5.75 MUSD0.00%
est5.75 MUSD-49.95%
est11.49 MUSD+200.00%
est3.83 MUSD-66.67%
est11.49 MUSD-42.25%
19.89 MUSD+236.92%
5.90 MUSD+570.91%
880,000.00USD—
0.00USD—
0.00USD—
0.00USD-100.00%
36,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Generation Bio Revenue

Generation Bio Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2022
880,000.00 USD
-141.18 M USD
-132.10 M USD
Jan 1, 2023
5.90 M USD
-138.56 M USD
-126.61 M USD
Jan 1, 2024
19.89 M USD
-142.39 M USD
-131.67 M USD
Jan 1, 2025 (e)
11.49 M USD
2.30 M USD
-64.55 M USD
Jan 1, 2026 (e)
3.83 M USD
765,866.00 USD
-25.07 M USD
Jan 1, 2027 (e)
11.49 M USD
2.30 M USD
-13.14 M USD
Jan 1, 2028 (e)
5.75 M USD
1.15 M USD
3.57 M USD
Jan 1, 2029 (e)
5.75 M USD
1.15 M USD
2.43 M USD

Generation Bio Margins

Generation Bio stock margins

The Generation Bio margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Generation Bio. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Generation Bio.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2022
-582.95 %
-16,043.41 %
-15,010.91 %
Jan 1, 2023
100.00 %
-2,346.93 %
-2,144.51 %
Jan 1, 2024
100.00 %
-715.82 %
-661.91 %
Jan 1, 2025 (e)
100.00 %
20.00 %
-561.89 %
Jan 1, 2026 (e)
100.00 %
20.00 %
-654.78 %
Jan 1, 2027 (e)
100.00 %
20.00 %
-114.41 %
Jan 1, 2028 (e)
100.00 %
20.00 %
62.13 %
Jan 1, 2029 (e)
100.00 %
20.00 %
42.20 %

Generation Bio Stock analysis

What does Generation Bio do? Generation Bio Co. is a genetic medicines company headquartered in Cambridge, Massachusetts, that focuses on creating a new class of gene therapy to provide durable and redosable treatment for patients suffering from both rare and prevalent diseases. The firm is developing a class of gene therapy utilizing its non-viral gene therapy platform to deliver genetic payloads to a range of tissues. The company’s non-viral gene therapy platform includes its DNA construct called closed-ended DNA (ceDNA), its cell-targeted lipid nanoparticle delivery system (ctLNP) and its established, scalable capsid-free manufacturing process. The firm is engineering its gene therapies to be redosable, which enable patient titration to reach the desired therapeutic expression and to maintain efficiency in a patient’s life. The firm is a preclinical stage company and have not identified a product candidate. Generation Bio is one of the most popular companies on Eulerpool.

Revenue Details

Understanding Generation Bio's Sales Figures

The sales figures of Generation Bio originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Generation Bio’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Generation Bio's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Generation Bio’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Generation Bio stock

The revenue of Generation Bio is 19.89 M USD in 2024.

The revenue of Generation Bio changed from 5.90 M USD to 19.89 M USD, representing a 236.92% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The revenue Generation Bio since 2006 – with annual values, charts, and detailed analysis.

Revenue is the total value of all goods sold in a period. It is calculated by multiplying the quantity of each product sold by its selling price. Revenue does not include any costs (material costs, personnel costs, etc.), whereas net proceeds only deduct revenue reductions associated with the sale (discounts, etc.).

The revenue's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The revenue's Generation Bio historically and in real time.

The revenue in assessing a stock

Revenue is an important financial measure used in the valuation of stocks. It is a measure of a company's economic activity and can serve as an indicator of the company's success. Revenue is considered one of the most important factors in stock valuation. In addition, revenue can also be used to calculate other financial measures such as earnings per share and price-earnings ratio.

History and utilization of revenue

Revenue has long been considered one of the most important financial indicators. It was used in the 19th century as one of the first financial indicators to measure a company's economic activity. Since then, revenue has been regularly used to evaluate companies.

Revenue is usually calculated as a percentage of the company's equity. It can also be used to determine the overall profitability of a company. There are many different types of revenue that can be used to measure a company's economic activity, such as gross revenue, net revenue, and revenue from international business.

The revenue can also be used to evaluate stocks. For example, the revenue of a company can be used to evaluate the success of the company. If a company has high revenue, it means that it is a profitable company because it has high demand for its products or services.

Calculation and Application of Revenue

In order to calculate a company's revenue, the company's income must be deducted from its expenses. The income can come from various sources, such as sales, licensing fees, services, etc. The expenses can include costs for production, procurement, inventory, sales, and administration.

The revenue can then be used to calculate various financial ratios. For example, the revenue can be used to calculate the price-earnings ratio (P/E ratio) of a company. This is a measure of a company's profitability, calculated by taking the ratio of the stock price to earnings per share.

Revenue can also be used to calculate earnings per share (EPS) of a company. This is a measure of a company's profit per share. EPS is calculated by dividing earnings by the number of shares issued.

Use of revenue by investors

Investors use revenue to evaluate stocks, as revenue is an indicator of a company's success. For example, an investor can compare a company's revenue to see how successful it is. An investor can also use a company's revenue to calculate its price-to-earnings ratio and earnings per share.

An example: An investor looks at a company that has a revenue of 25 million euros. He compares this revenue to that of the competitor, which has a revenue of 35 million euros. The investor can then see that the company with 25 million euros in revenue is less successful than the company with 35 million euros in revenue.

Advantages and Disadvantages of Revenue.

Revenue is a very useful tool for valuing stocks as it measures a company's economic activity. Revenue can also be used to calculate other financial ratios such as the price-earnings ratio and earnings per share.

However, one disadvantage is that revenue alone is not a meaningful indicator of a company's success. It is important to consider revenue in comparison to other financial metrics such as earnings per share and price-to-earnings ratio to get a complete picture of the company.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Generation Bio

All Key Metrics — Generation Bio